microRNA-4500 inhibits human glioma cell progression by targeting IGF2BP1

Zheng-Wei Li1, Min Xue2, Bing-Xin Zhu1

  • 1Neurosurgery Department, Xuzhou Children's Hospital, Xuzhou Medical University, Xuzhou, China.

Insights

MicroRNA-4500 (miR-4500) suppresses glioma progression by targeting Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1). Lower miR-4500 levels in glioma tissues correlate with higher IGF2BP1, confirming its role in tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Overexpression of Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is linked to glioma cell progression.
  • MicroRNAs (miRNAs) represent a potential therapeutic strategy for silencing oncogenes like IGF2BP1.

Purpose of the Study:

  • To investigate the potential of microRNA-4500 (miR-4500) to silence IGF2BP1 in glioma cells.
  • To elucidate the role of the miR-4500/IGF2BP1 axis in glioma cell behavior and its clinical relevance.

Main Methods:

  • Bioinformatic analysis to predict miR-4500 targeting of IGF2BP1 3'-untranslated region (3'-UTR).
  • In vitro experiments involving ectopic miR-4500 overexpression and inhibition in A172 and primary human glioma cells.
  • CRISPR/Cas9 gene editing to knock out IGF2BP1 in A172 cells.
  • Analysis of IGF2BP1 and its target genes (Gli1, IGF2, c-Myc) expression.
  • Assessment of glioma cell proliferation, survival, migration, and invasion.
  • Correlation analysis of miR-4500 and IGF2BP1 levels in human glioma tissues.

Main Results:

  • Bioinformatic analysis confirmed miR-4500's putative targeting of the IGF2BP1 3'-UTR.
  • Ectopic overexpression of wild-type miR-4500 (but not mutant) downregulated IGF2BP1 and its targets (Gli1, IGF2, c-Myc) in glioma cells.
  • miR-4500 overexpression inhibited glioma cell growth, survival, proliferation, migration, and invasion.
  • miR-4500 inhibition increased IGF2BP1 expression and promoted glioma cell progression.
  • IGF2BP1 knockout inhibited A172 cell progression, and miR-4500's effects were abolished in these cells.
  • Human glioma tissues showed downregulated miR-4500 and upregulated IGF2BP1.

Conclusions:

  • miR-4500 functions as a tumor suppressor in human glioma by directly targeting and downregulating IGF2BP1.
  • The miR-4500/IGF2BP1 axis is a critical regulator of glioma cell progression.
  • miR-4500 represents a potential therapeutic target for glioma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.9K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.8K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.3K